Clinical significance of hepatitis B surface antigen mutants

Area of Science:

• Hepatology
• Virology
• Immunology

Background:

• Hepatitis B virus (HBV) infection affects nearly 300 million people globally, causing over 1 million deaths annually from cirrhosis and liver cancer.
• Mutations in the hepatitis B surface antigen (HBsAg) are frequently observed, primarily single amino acid substitutions or nucleotide deletions.
• These mutations often occur in the S region, but also in the pre-S1 and pre-S2 regions.

Purpose of the Study:

• To review the biological and clinical implications of HBsAg mutants.
• To highlight the association of specific mutations with immune escape and treatment challenges.
• To discuss the link between pre-S region deletions and hepatocellular carcinoma development.

Main Methods:

• Literature review of studies on HBsAg mutations.
• Analysis of reported biological and clinical consequences of HBV variants.
• Synthesis of information on mutation locations and their effects.

Main Results:

• Mutations in the HBsAg
• a
• determinant are linked to immune escape, leading to HBV vaccine failure and diagnostic challenges.
• Deletions in the pre-S1 or pre-S2 regions are associated with an increased risk of hepatocellular carcinoma.
• Most mutations involve single amino acid substitutions, with nucleotide deletions being less common.

Conclusions:

• HBsAg mutations have significant biological and clinical implications for HBV infection management.
• Understanding these mutants is essential for developing effective diagnostics, vaccines, and therapies.
• Further research into HBV variants can improve strategies for preventing and treating HBV-related liver diseases.